Lv3
370 积分 2026-07-16 加入
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
2天前
已完结
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
5天前
已完结
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
1个月前
已完结
No evidence for brain renin–angiotensin system activation during DOCA-salt hypertension
2个月前
已完结
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
2个月前
已完结
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
2个月前
已完结
IL-31 blockade elevates thymus and activation-regulated chemokine by lifting LAMP3+CD1c+ mature dendritic cells from calcitonin gene–related peptide–calcitonin receptor–like neuroimmune suppression in atopic dermatitis
2个月前
已完结
Nemolizumab‐induced exacerbation of atopic dermatitis
3个月前
已完结
A case of bullous pemphigoid after nemolizumab administration
3个月前
已完结
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
4个月前
已完结